Proteomic methods for biomarker discovery and validation. Are we there yet?
- PMID: 26186709
- DOI: 10.1586/14789450.2015.1064771
Proteomic methods for biomarker discovery and validation. Are we there yet?
Abstract
Noninvasive molecular biomarkers are becoming attractive tools to monitor disease progression, aid drug development programs and use as surrogate outcome measures in clinical trials. Cutting edge proteomic methods to assay biomarkers in body fluids have been developed in the past few years, but transitioning them to clinical practice has been slow and depends on the qualification of both the method and the biomarker.
Keywords: SomaScan; antibody bead arrays; biomarkers; biomarkers validation; proteomics; targeted mass spectrometry.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous